Platform-based gene therapy: From prevalent to rare neurological diseases

​Join the Imperial Neurotech Society for a talk by Romain Joubert, Senior Director at AviadoBio.
The session will explore how platform-based gene therapy approaches can accelerate the development of treatments for rare neurological diseases. Using AviadoBio’s vMiX™ platform as a case study, we will discuss how transferable components of gene therapy platforms can be leveraged across neurological indications.